Titan Pharmaceuticals (de) Overview

Titan Pharmaceuticals (de) EBIT

EBIT (Earnings Before Interest and Taxes) analysis for TTNP.

Quarterly EBIT

-$803.00K

↓ 6.5% YoY

As of Sep 30, 2025

Annual EBIT (TTM)

-$2.66M

↑ 54.4% YoY

Trailing 12 months ending Sep 30, 2025

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin